Colofac 135 mg Coated tablets.
PDF Leaflet Revision Date: 26 January 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Irritable bowel syndrome with abdominal pain.
Dosage (summary)
1 tablet three times daily before meals.
Special Populations
- Patients with lactose intolerance
- Patients with sucrose intolerance
Pregnancy & Breastfeeding
Not recommended in pregnancy; unknown if excreted in breast milk.
Key Drug Interactions
- No significant interactions with alcohol
Contraindications
- Hypersensitivity to mebeverine or excipients
Common side effects
- Dizziness
- Headache
- Diarrhoea
- Constipation
Counselling Points
- Take with sufficient water
- Do not chew tablets
- Report any allergic reactions
Serious warnings
- Safety in pregnancy not established
- May cause dizziness
Important Disclaimer
The Colofac 135 mg Coated tablets. professional information leaflet below is the property of Abbott Laboratories South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
